---
figid: PMC6704288__ol-18-03-2977-g04
figlink: /pmc/articles/PMC6704288/figure/f5-ol-0-0-10643/
number: Figure 5
caption: Proposed model of the combined effect of ROR1 inhibition and erlotinib treatment
  in non-small cell lung cancer cell lines via inhibition of the AKT/mTOR signaling
  pathway. Inhibition of ROR1 significantly decreased the activity of IRS-1, AKT,
  mTOR and p70S6K, and activated GSK-3α/β and PTEN, which are two negative regulators
  of PI3K/AKT signaling. This enhances cell apoptosis, and reduces cell proliferation
  and survival. ROR1, receptor tyrosine kinase-like orphan receptor 1; IRS-1, insulin
  receptor substrate 1; GSK-3α/β, glycogen synthase kinase-3α/β; p, phosphorylated;
  EGFR, epidermal growth factor receptor.
pmcid: PMC6704288
papertitle: Blocking ROR1 enhances the roles of erlotinib in lung adenocarcinoma cell
  lines.
reftext: Hui-Li Wang, et al. Oncol Lett. 2019 Sep;18(3):2977-2984.
pmc_ranked_result_index: '33214'
pathway_score: 0.5185136
filename: ol-18-03-2977-g04.jpg
figtitle: Proposed model of the combined effect of ROR1 inhibition and erlotinib treatment
  in non-small cell lung cancer cell lines via inhibition of the AKT/mTOR signaling
  pathway
year: '2019'
organisms: Homo sapiens
ndex: cf8c7b18-df1c-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6704288__ol-18-03-2977-g04.html
  '@type': Dataset
  description: Proposed model of the combined effect of ROR1 inhibition and erlotinib
    treatment in non-small cell lung cancer cell lines via inhibition of the AKT/mTOR
    signaling pathway. Inhibition of ROR1 significantly decreased the activity of
    IRS-1, AKT, mTOR and p70S6K, and activated GSK-3α/β and PTEN, which are two negative
    regulators of PI3K/AKT signaling. This enhances cell apoptosis, and reduces cell
    proliferation and survival. ROR1, receptor tyrosine kinase-like orphan receptor
    1; IRS-1, insulin receptor substrate 1; GSK-3α/β, glycogen synthase kinase-3α/β;
    p, phosphorylated; EGFR, epidermal growth factor receptor.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - BCL2
  - AKT1
  - AKT2
  - PIK3CG
  - PIK3R3
  - AKT3
  - PIK3CD
  - GSK3B
  - IRS1
  - EGFR
  - GSK3A
  - PIK3R4
  - PIK3R6
  - MTOR
  - PIK3CA
  - PIK3CB
  - PTEN
  - ROR1
  - PIK3R5
  - erlotinib
  - Cancer
genes:
- word: Bcl-2
  symbol: Bcl-2
  source: hgnc_alias_symbol
  hgnc_symbol: BCL2
  entrez: '596'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: GSK3
  symbol: GSK3
  source: bioentities_symbol
  hgnc_symbol: GSK3B
  entrez: '2932'
- word: IRS-1
  symbol: IRS1
  source: hgnc_symbol
  hgnc_symbol: IRS1
  entrez: '3667'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: GSK3
  symbol: GSK3
  source: bioentities_symbol
  hgnc_symbol: GSK3A
  entrez: '2931'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: ROR1
  symbol: ROR1
  source: hgnc_symbol
  hgnc_symbol: ROR1
  entrez: '4919'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
chemicals:
- word: erlotinib
  source: MESH
  identifier: C400278
diseases:
- word: Cancer
  source: ''
  identifier: ''
---
